Here is the latest stock price and chart of Torrent Pharma. For more details, see the Torrent Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Know More: Which way are the markets & the mutual fund industry headed?
Live BSE Quotes | Jan 27, 2021 (Close) | ||
---|---|---|---|
Price (Rs)2,646.25 | Open (Rs) 2,636.15 | High (Rs) 2,656.25 | Low (Rs) 2,604.35 |
% Change0.39 | Volume 5,548 | Value (Rs) 14,631,520 | 52-Week H/L 3,040.00 / 1,619.00 |
Live NSE Quotes | Jan 27, 2021 (Close) | ||
---|---|---|---|
Price (Rs)2,648.15 | Open (Rs) 2,640.90 | High (Rs) 2,657.30 | Low (Rs) 2,602.50 |
% Change0.49 | Volume 443,542 | Value (Rs) 1,174,565,747 | 52-Week H/L 3,031.20 / 1,583.25 |
Change | |||||
---|---|---|---|---|---|
1 Day 0.39% | 1 Month -5.17% | 3 Months 1.76% | 1 Year 30.56% | 5 Years (CAGR)* 13.63% | 10 Years (CAGR)* 24.53% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 70.66 | P/E Ratio (x) 37.45 | Market Cap (Rs m) 447,904.28 | P/BV (x) 9.48 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
TORRENT PHARMA last traded price was up 0.4% to Rs 2,646.3 on the BSE. On the NSE, TORRENT PHARMA last traded price was up 0.5% to Rs 2,648.2. The total volume of shares traded was 0.4 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 1.7%. And the benchmark S&P BSE SENSEX was at 47,409.9 (down 1.9%).
Over the last 30 days, the TORRENT PHARMA share price is down 5.2%. And over the last one year, TORRENT PHARMA share price is up 30.6%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed heavy selling pressure today despite the US administration saying it would bring a stimulus package even without the opposition's support.
For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.
For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More